What to Expect After RPNI Surgery for Nerve Pain

Written by Brian P. Kelley, MD — Dual Board-Certified Plastic & Hand Surgeon
Affiliate Faculty, Dell Medical School at The University of Texas at Austin
Seton Ascension Institute for Reconstructive Plastic and Hand Surgery
Medically reviewed: May 10, 2026 · Last updated: May 10, 2026
Educational content. Not a substitute for individualized medical evaluation.

‍
Introduction

Regenerative Peripheral Nerve Interface (RPNI) surgery for established nerve pain is a fundamentally different experience from many other operations, because the result you are waiting for is not a healed incision — it is a change in how a nerve behaves over months. Patients who undergo RPNI to treat an existing painful neuroma often expect the relief to track with the surgical healing. It does not. The incision heals in weeks; the nerve reorganizes over months. Understanding that distinction up front is the single most useful thing a patient considering this surgery can do.

I trained in plastic surgery, microsurgery, and hand surgery at the University of Michigan, where RPNI was developed by Dr. Paul Cederna and the Neuromuscular Laboratory, and I was involved in RPNI surgery during the period the technique was being pioneered. Peripheral nerve surgery has remained central to my practice and my published work since.¹ I now practice as a dual board-certified plastic and hand surgeon in Austin, Texas, as an Affiliate Faculty at Dell Medical School at The University of Texas at Austin, and as a partner at the Seton Ascension Institute for Reconstructive Plastic and Hand Surgery.

This post is specifically about therapeutic RPNI — surgery performed to treat an existing, symptomatic neuroma — rather than prophylactic RPNI performed at the time of amputation to prevent a neuroma from forming. The recovery, the timeline, and the expectations differ between the two settings, and this discussion focuses on the therapeutic case.

A Quick Reminder of What RPNI Does

When a nerve is divided — by amputation, trauma, or prior surgery — and has no target to reinnervate, the regenerating axons form a disorganized, hyperexcitable mass called a neuroma. A neuroma generates spontaneous and provoked pain signals, often experienced as sharp, electrical, or burning pain at the site or in a phantom distribution.

RPNI addresses this by giving the nerve a physiologic target. In the therapeutic setting, the surgeon excises the existing neuroma to reach healthy nerve, then implants the freshened nerve end into a small free graft of the patient's own muscle. The regenerating axons grow into the muscle graft and reinnervate it, forming an organized neuromuscular target rather than a disorganized neuroma. This reorganization is what relieves the pain — and it is a biological process that takes time, which is why the recovery timeline is measured in months rather than weeks.

The Operation and Immediate Recovery

Therapeutic RPNI is often an outpatient procedure or a short-stay operation, depending on the location and extent of the surgery, whether it is combined with other procedures, and the patient's overall health. It is commonly performed under regional anesthesia, general anesthesia, or a combination.

The surgical incision is placed to access the neuroma and to harvest a small muscle graft, usually from a nearby muscle. The donor site for the muscle graft is minor and generally heals without functional consequence, because only a small segment of expendable muscle is taken.

In the first one to two weeks, the focus is incisional healing. Expect the typical postoperative course of any minor-to-moderate surgical incision: some pain at the surgical site that is distinct from the nerve pain being treated, swelling, bruising, and activity restriction to protect the healing wound. Pain at the incision during this period is expected and is not a sign that the procedure failed — it is surgical pain, not neuroma pain, and it resolves as the wound heals.

The Critical Point: Surgical Healing and Nerve Healing Are Different Timelines

This is the concept that matters most, and it is the one patients most often misunderstand.

Surgical healing is what happens to the incision and the soft tissues. It follows the predictable course of any wound — inflammation, then tissue repair, then remodeling — and the visible signs (closed incision, resolved swelling, faded bruising) are largely complete within several weeks.

Nerve healing is what happens inside, where the implanted nerve grows into the muscle graft and reorganizes. This follows the biology of peripheral nerve regeneration, which is slow. Regenerating axons advance at roughly one millimeter per day, and the reorganization of the nerve's signaling — the change that actually relieves the pain — develops gradually over months.

A patient whose incision has fully healed at three weeks may still have significant or even worsening nerve pain, because the nerve reorganization is far from complete. This is normal and expected. The mistake patients make is interpreting persistent nerve pain at three or six weeks as surgical failure. The honest framing is that meaningful pain relief from RPNI typically develops over the first several months and may continue to improve for a year or more.

Timeline of Changes in Nerve Perception

The way nerve sensation and pain change after RPNI follows a recognizable, if variable, pattern. Individual experience differs substantially, and the timeline below describes typical ranges rather than guarantees.

Weeks 1–4. Surgical pain dominates this period. The nerve pain being treated may be unchanged, temporarily worse from the surgical manipulation, or beginning to shift. Some patients notice the character of their pain change before its intensity does — for example, a sharp shooting pain becoming a duller ache. The incision heals during this window.

Months 1–3. This is when many patients may begin to notice meaningful change in the nerve pain. As the implanted nerve grows into the muscle graft and begins to reinnervate it, the disorganized signaling that drove the pain starts to reorganize. Pain intensity often begins to decrease in this window, though it is rarely complete. Some patients experience transient sensations — tingling, mild electrical feelings, or sensitivity at the surgical site — that reflect the nerve regenerating and are generally a sign of the expected biological process rather than a complication.

Months 3–6. Continued improvement is typical in this window as reinnervation matures. Many patients reach the majority of their eventual pain relief by around six months, though the trajectory varies. Phantom sensations and residual limb sensations may continue to evolve.

Months 6–12 and beyond. Improvement can continue gradually through the first year and sometimes longer. The nerve and its new muscle target stabilize over this period. Patients who have reached a plateau by six to twelve months generally have a durable result, as RPNI constructs have demonstrated long-term stability in the published literature.

The variability here is real and worth emphasizing. Some patients experience rapid and substantial relief; others improve slowly and incompletely. The patients most likely to have a less complete result are those with very long-standing neuromas, multiple prior surgeries at the site, or pain that has a significant central sensitization component — pain that the nervous system has, over time, partly relocated from the peripheral nerve to the spinal cord and brain. Central sensitization does not respond as completely to a peripheral operation, which is part of why earlier intervention tends to produce better outcomes.

What Imaging Shows During Healing

Patients sometimes undergo imaging during recovery, particularly if there is a question about whether a neuroma is recurring or whether a new soft-tissue change is concerning. It is worth knowing that RPNI constructs have a characteristic and expected appearance on ultrasound and MRI as they heal, and that these normal post-surgical changes can be mistaken for problems by clinicians unfamiliar with the procedure.

A 2026 scoping review of the postoperative imaging characteristics of TMR and RPNI examined the expected ultrasound and MRI appearance of these nerve constructs and noted that, while the imaging features are consistent, they are not yet well documented — meaning a radiologist or clinician who has not specifically studied RPNI imaging may misread a normal, healing RPNI construct as an abnormality.² If you undergo imaging during recovery, it is helpful for the interpreting radiologist to know that you have had RPNI surgery, so that the expected post-surgical changes are read in context. Morphologic changes at the RPNI site over time are part of the normal physiologic process of nerve regeneration and muscle reinnervation.

Outcomes: What the Literature Shows

The published evidence on RPNI and the related technique TMR for treating established nerve pain is generally favorable, with the consistent caveat that the evidence base is still maturing.

A 2024 systematic review and meta-analysis comparing nerve interface procedures against standard management in limb amputation found reductions in phantom limb pain, residual limb pain, and painful neuroma incidence with these techniques relative to standard treatment.³ A 2023 systematic review quantifying pain reduction for both prophylactic and therapeutic applications found meaningful reductions in pain across the studies reviewed.⁴ The foundational clinical work describing RPNI for the management of postamputation neuroma came from the University of Michigan group that developed the technique.⁵

In the oncologic amputee population — patients who undergo amputation as part of cancer treatment, a group with high rates of pain and opioid use — a 2023 cohort study found that TMR and RPNI were safe and were associated with significant reductions in residual limb pain and phantom limb pain alongside improvements in patient-reported outcomes. In that study, patient opioid use decreased from approximately 86% before surgery to approximately 38% afterward.⁶ A 2024 case-control study of combined TMR and RPNI found a significantly lower rate of continued opioid use at 90 days after surgery in the treated group compared to controls.⁷

The honest caveats matter. Much of the evidence consists of cohort studies, case-control studies, and systematic reviews of these rather than large randomized trials directly comparing therapeutic RPNI to alternatives. Follow-up duration and outcome measures vary across studies. The consistent direction is favorable, and RPNI is a well-adopted technique at peripheral nerve centers, but patients should understand that the evidence base, while solid and growing, is not yet built primarily on randomized data. A clinical review of the evolving landscape of TMR and RPNI published in 2026 reflects how the field continues to develop.⁸

Risks

RPNI for nerve pain is generally well tolerated, with a risk profile similar to other peripheral nerve operations. Recognized risks include:

Bleeding, infection, and the normal risks of surgery and anesthesia. Incomplete pain relief — some patients experience partial rather than complete improvement, particularly those with long-standing neuromas or central sensitization. Recurrent neuroma — although RPNI is specifically designed to prevent neuroma recurrence, it is not guaranteed in every case. New or persistent pain at the surgical site. Minor donor-site effects from harvesting the small muscle graft, which are generally inconsequential. A recovery period during which nerve pain may persist before the biological reorganization produces relief, which patients should understand is expected rather than a sign of failure.

No operation for nerve pain is guaranteed to eliminate pain. Honest counseling about the realistic range of outcomes — including the possibility of partial relief — is part of the decision to proceed.

How to Set Yourself Up for the Best Result

A few practical points for patients in recovery:

Expect a months-long timeline and plan for it. The most common source of disappointment after RPNI is the expectation of fast relief. Patients who understand from the outset that the meaningful change develops over months are better prepared and generally more satisfied.

Distinguish surgical pain from nerve pain. In the early weeks, incisional pain is expected and resolves with healing. It is separate from the nerve pain being treated. Confusing the two leads patients to conclude prematurely that the surgery failed.

Continue any prescribed pain management during the transition. RPNI does not produce instant relief, so the multimodal pain management plan in place before surgery typically continues during the recovery period and is adjusted as the nerve pain improves. Do not abruptly stop pain medications without guidance from your care team.

Engage with rehabilitation if it is part of your plan. Depending on the location of the surgery and your broader situation, physical therapy, desensitization techniques, and prosthetic rehabilitation may be part of recovery. Engagement with these supports the overall outcome.

Report concerning symptoms promptly. Expanding redness, fever, drainage, or a sudden change should be reported to your surgical team. Gradual, slow improvement in nerve pain is expected; sudden new problems are not.

‍

Related Topics

• TMR vs. RPNI: what is the difference?
• TMR and RPNI for nerve pain and amputations
• Peripheral nerve surgery, RPNI, and TMR
• Nerve repair and reconstruction
• Replantation and revascularization
• Breast Sensation After Mastectomy

‍

Closing Disclaimer

This article is educational and does not establish a doctor-patient relationship. It does not replace individualized consultation, examination, or review of personal medical history. Patients recovering from RPNI surgery should follow their surgeon's specific instructions, which take precedence over any general guidance on this page. If you experience concerning symptoms during recovery, contact your surgical team.